Patient-Reported Outcomes in Two Randomized, Controlled Trials (RCTs) in Patients with Rheumatoid Arthritis (RA) Treated with Tocilizumab (TCZ) Monotherapy Compared with Methotrexate (MTX) or Adalimumab (ADA)

被引：0
|
作者：
Strand, Vibeke [1 ]
Lampl, Kathy [2 ]
Birchwood, Christine [2 ]
Pei, Jinglan [2 ]
Tuckwell, Katie [3 ]
Finch, Rebecca [3 ]
Gabay, Cem [4 ]
Kavanaugh, Arthur [5 ]
Jones, Graeme [6 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[2] Genentech Inc, 1 DNA Way,MS 304, San Francisco, CA 94080 USA
[3] Roche Prod Ltd, Welwyn Garden City, Herts, England
[4] Geneva Univ Hosp, Rheumatol, Dept Rheumatol, Geneva, Switzerland
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
[6] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2515
引用
收藏
页数：4
相关论文
共 50 条
  • [1] CHANGES IN LIPOPROTEIN(A) AFTER TREATMENT WITH TOCILIZUMAB (TCZ), ADALIMUMAB (ADA), AND METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Gabay, C.
    McInnes, I.
    Kavanaugh, A.
    Tuckwell, K.
    Collinson, N.
    Klearman, M.
    Green, J.
    Sattar, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 124 - 124
  • [2] TOCILIZUMAB (TCZ) AS COMBINATION THERAPY AND AS MONOTHERAPY VS METHOTREXATE (MTX) IN MTX-NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: PATIENT-REPORTED OUTCOMES (PROS) FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Burmester, G.
    Blanco, R.
    Keiserman, M.
    Rigby, W.
    van Vollenhoven, R. F.
    Dimonaco, S. M.
    Grzeschik, S. M.
    Mitchell, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 672 - 672
  • [3] DISTINCT BIOMARKERS ENRICH FOR CLINICAL RESPONSE TO TOCILIZUMAB (TCZ) AND ADALIMUMAB (ADA) IN ADACTA: A HEAD-TO-HEAD MONOTHERAPY STUDY IN PATIENTS (PTS) WITH METHOTREXATE (MTX)-IR RHEUMATOID ARTHRITIS (RA)
    Herman, A.
    Musselman, D.
    Fischer, S.
    Setiadi, A.
    Gabay, C.
    Kavanaugh, A.
    Klearman, M.
    Song, A.
    Townsend, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 206 - 206
  • [4] AUSTRALIAN ECONOMIC EVALUATION OF TOCILIZUMAB (TCZ) MONOTHERAPY VS. ADALIMUMAB (ADA) MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) BASED ON THE ADACTA TRIAL
    Ngo, P.
    Sorathia, R.
    Todd, C.
    Jones, G.
    Nash, P.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 12 - 12
  • [5] Patient-Reported Outcomes Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: Results from a Randomized Controlled Trial
    Kremer, Joel
    Rigby, William F. C.
    Singer, Nora
    Birchwood, Christine
    Gill, Darcy
    Reiss, William
    Best, Jennie
    Pei, Jinglan
    Michalska, Margaret
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] A COMPARISION OF TOCILIZUMAB (TCZ) AND METHOTREXATE (MTX) MONOTHERAPIES IN MTX- OR DMARD-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Jones, G.
    Gomez-Reino, J. J.
    Lowenstein, M. B.
    Tomero, J.
    Sebba, A.
    Alecock, E.
    Guarin, E.
    Genovese, M.
    RHEUMATOLOGY, 2010, 49 : I5 - I5
  • [7] LONG-TERM EFFICACY OF TOCILIZUMAB (TCZ) MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) PREVIOUSLY METHOTREXATE (MTX) NAIVE OR MTX FREE FOR 6 MONTHS
    Jones, G.
    Taylor, A.
    Sebba, A.
    Anisfeld, A.
    Devenport, J.
    Bernasconi, C.
    Smart, D.
    Galindez, D.
    Mpofu, C.
    Gomez-Reino, J.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 12 - 12
  • [8] The AMBITION study: Superiority of tociluzumab (TCZ) vs methotrexate (MTX) monotherapy in patients with rheumatoid arthritis (RA)
    Jones, G.
    Gu, J. R.
    Lowenstein, M.
    Calvo, A.
    Gomez-Reino, J. J.
    Siri, D.
    Tomsic, M.
    Blackburn, R.
    Woodworth, T.
    Sebba, A.
    Genovese, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S618 - S618
  • [9] PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB COMPARED WITH PLACEBO OR INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH CSDMARDS
    Strand, V.
    Lampl, K.
    Birchwood, C.
    Pei, J.
    Tuckwell, K.
    Finch, R.
    Kivitz, A.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 581 - 582
  • [10] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Strand, Vibeke
    Gossec, Laure
    Proudfoot, Clare W. J.
    Chen, Chieh-I
    Reaney, Matthew
    Guillonneau, Sophie
    Kimura, Toshio
    van Adelsberg, Janet
    Lin, Yong
    Mangan, Erin K.
    van Hoogstraten, Hubert
    Burmester, Gerd R.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
12345